These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9746402)

  • 21. Polymyositis--an unusual manifestation of chronic graft-versus-host disease.
    George B; Danda D; Chandy M; Srivastava A; Mathews V
    Rheumatol Int; 2001 May; 20(4):169-70. PubMed ID: 11411964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A.
    Liem LM; van Noort JT; Goulmy E
    Bone Marrow Transplant; 1996 Jul; 18(1):73-8. PubMed ID: 8831998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
    Weisdorf D; Filipovich A; McGlave P; Ramsay N; Kersey J; Miller W; Blazar B
    Bone Marrow Transplant; 1993 Nov; 12(5):531-6. PubMed ID: 8298565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant.
    Leano AM; Miller K; White AC
    Bone Marrow Transplant; 2000 Nov; 26(10):1117-20. PubMed ID: 11108314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. rhGM-CSF after allogeneic bone marrow transplantation from unrelated donors: a pilot study of cyclosporine and prednisone as graft-versus-host disease prophylaxis.
    Nemunaitis J; Anasetti C; Bianco JA; Hasen J; Singer JW
    Leuk Lymphoma; 1993 Jun; 10(3):177-81. PubMed ID: 8220115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical acute graft-versus-host disease.
    Shin J; Hong W; Song H; Choi G; Kim YC
    Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Canine Model of Chronic Graft-versus-Host Disease.
    Graves SS; Rezvani A; Sale G; Stone D; Parker M; Rosinski S; Spector M; Swearingen B; Kean L; Storb R
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):420-427. PubMed ID: 28013013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic cutaneous graft-versus-host disease in man.
    Shulman HM; Sale GE; Lerner KG; Barker EA; Weiden PL; Sullivan K; Gallucci B; Thomas ED; Storb R
    Am J Pathol; 1978 Jun; 91(3):545-70. PubMed ID: 26221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graft versus host disease in allogeneic stem cell transplantation--3 1/2 years experience.
    Hashmi K; Khan B; Ahmed P; Hussain I; Altaf C; Raza S; Iqbal H; Khan MA; Malik HS; Naeem M; Kamal K; Anwar M
    J Pak Med Assoc; 2005 Oct; 55(10):423-7. PubMed ID: 16304849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation.
    Ogawa H; Soma T; Hosen N; Tatekawa T; Tsuboi A; Oji Y; Tamaki H; Kawakami M; Ikegame K; Murakami M; Fujioka T; Kim EH; Oka Y; Sugiyama H
    Transplantation; 2002 Jul; 74(2):236-43. PubMed ID: 12151737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thalidomide responsive chronic pulmonary GVHD.
    Forsyth CJ; Cremer PD; Torzillo P; Iland HJ; Young GA
    Bone Marrow Transplant; 1996 Feb; 17(2):291-3. PubMed ID: 8640183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.
    Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB
    Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Koehler MT; Howrie D; Mirro J; Neudorf S; Blatt J; Corey S; Wollman M; Kelly-Ekeroth V; Reyes J
    Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
    Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
    Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD.
    Marks C; Stadler M; Häusermann P; Wolff D; Buchholz S; Stary G; Lee S; Lawitschka A; Bertz H
    Br J Dermatol; 2011 Jul; 165(1):18-29. PubMed ID: 21466534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease.
    Leblond V; Zouabi H; Sutton L; Guillon JM; Mayaud CM; Similowski T; Beigelman C; Autran B
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1056-61. PubMed ID: 7921436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graft-versus-host disease-related polymyositis.
    Maillard-Lefebvre H; Morell-Dubois S; Lambert M; Charlanne H; Launay D; Hachulla E; Yakoub-Agh I; Hatron PY
    Clin Rheumatol; 2010 Apr; 29(4):431-33. PubMed ID: 20069327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.